Prosecutors allege that Shachar controlled four Southern California hospice companies, recruited ineligible beneficiaries through cash payments and gifts, purchased identifying information belonging to deceased patients, and caused Medicare to pay nearly $26.9 million on false claims
WASHINGTON, DC, August 26, 2026 — Los Angeles-area hospice owner Oren David Shachar stands accused of directing a sprawling Medicare fraud operation that allegedly converted end-of-life benefits into a revenue engine built around ineligible patients, paid referrals, fabricated records, and identities belonging to people who had already died.
The United States Department of Justice says Shachar and two alleged collaborators were charged through a 16-count federal indictment after investigators traced approximately $27,731,000 in hospice claims submitted between February 2021 and March 2026 through four companies under his control.
Medicare allegedly paid those hospices approximately $26,908,000, meaning the government disbursed nearly 97 cents for every dollar billed before the operation was interrupted, a conversion rate that illustrates how ordinary-looking provider claims can move enormous sums before investigators reconstruct their underlying clinical and financial history.
Shachar, 59, of Van Nuys, and Abraham Shin, 66, of Corona, were arrested June 18 and arraigned in federal court in Los Angeles, while Jeannie Choi, 57, of Torrance, was arrested several days later in connection with the same alleged conspiracy.
Every accusation remains unproven, and Shachar, Shin, and Choi are presumed innocent unless prosecutors establish guilt beyond a reasonable doubt at trial, a constitutional safeguard that remains essential even when an indictment contains unusually detailed allegations, large payment totals, and disturbing descriptions involving deceased beneficiaries.
Four hospices allegedly formed one billing network
The indictment identifies Gentle Touch Hospice Care in Valley Glen, Oxford Hospice Care in Montclair, Art of Hospice in Encino, and Holly Trinity Hospice in Glendale as the four entities Shachar allegedly owned, controlled, and operated during different portions of the charged period.
Rather than portraying those companies as isolated businesses with unrelated compliance failures, prosecutors describe them collectively as a coordinated platform through which patients could be enrolled, claims could be distributed, referral payments could be managed, and billing patterns could allegedly be adjusted to reduce scrutiny.
That structure matters because a network of separate provider numbers, business addresses, bank accounts, staff members, and patient rosters can make suspicious activity appear dispersed, even when investigators later allege that one operator retained decision-making and financial control.
Federal prosecutors contend that Shachar personally met Medicare beneficiaries whom he allegedly knew were not terminally ill, presenting his companies as providers focused on general quality-of-life improvements while concealing the more consequential reality that hospice is legally and medically reserved for end-of-life care.
The alleged presentation was not merely a marketing distinction, because electing hospice changes how Medicare pays for treatment associated with a terminal diagnosis, potentially limiting coverage for curative services and altering the beneficiary’s relationship with primary physicians and other medical providers.
According to the indictment, prospective and enrolled patients were allegedly not fully told that a physician needed to certify a terminal prognosis or that accepting hospice benefits could affect access to Medicare coverage for treatment intended to cure the illness underlying their enrollment.
Why Medicare hospice eligibility carries exceptional consequences
Medicare generally treats a person as terminally ill for hospice purposes when a physician certifies that the individual’s life expectancy is six months or less if the illness follows its normal course, while the patient must affirmatively elect comfort-focused care instead of certain curative benefits.
That framework exists because hospice combines nursing, medication, equipment, counseling, therapy, social services, and spiritual support for patients approaching death, making accurate eligibility assessments fundamental to both humane care and responsible stewardship of a benefit financed by taxpayers.
The system also requires certifications, election forms, patient identifiers, dates of service, physician information, and periodic face-to-face evaluations, creating a documentary chain that should connect every submitted claim to an actual patient, a defensible prognosis, and services genuinely delivered during the reported period.
Prosecutors allege that the Shachar operation corrupted several points along that chain, beginning with recruitment and continuing through certification, record creation, billing, and payment, turning safeguards meant to document legitimate care into components of an allegedly false administrative narrative.
For living beneficiaries, the indictment says the central eligibility problem was straightforward but profound: some patients allegedly were not terminally ill, yet they were enrolled and repeatedly billed as hospice recipients while payments or material benefits encouraged them to remain inside the participating companies.
For deceased beneficiaries, the accusation is even more stark, because prosecutors say records were created after death to make it appear that nurses had evaluated those individuals and physicians had certified terminal illness while the patients were still alive.
Cash, gifts, and referral payments allegedly sustained enrollment
The indictment alleges that Shachar, directly or through marketers, offered some living beneficiaries as much as $400 each month to remain enrolled, while additional inducements allegedly included groceries, alcohol, personal-care supplies, medical equipment, televisions, massages, furniture, and reclining armchairs.
Those alleged benefits may appear modest beside the multimillion-dollar billing total, yet recurring household assistance can exert substantial influence over elderly, disabled, financially stressed, or medically vulnerable people who may not fully understand the clinical classification and coverage consequences attached to hospice enrollment.
Prosecutors further allege that beneficiaries could receive $100 or $200 for referring another patient, effectively extending recruitment beyond professional marketers and turning existing enrollees into potential sources of additional names whose Medicare eligibility could generate continuing reimbursements.
Outside the patient population, Shachar allegedly paid marketers about $700 for each living beneficiary each month the person remained billable to Medicare, a recurring arrangement that would reward long enrollment rather than careful reassessment of medical eligibility.
The indictment says Shin and Choi participated as marketers during 2025, with Shachar allegedly paying referral compensation and using information they supplied to expand both the living-patient and deceased-patient portions of the operation described by the grand jury.
Federal anti-kickback rules are designed to prevent medical choices from being purchased because paid referrals can redirect patients based on financial incentives rather than clinical judgment, and they can also taint every resulting claim regardless of whether any underlying services occurred.
In two representative anti-kickback counts, prosecutors allege that Shachar paid $300 to Choi for one referral in September 2025 and another $300 to Shin for a referral in January 2026, although the broader conspiracy allegations describe multiple payment methods and substantially larger recurring arrangements.
Deceased beneficiaries allegedly became billing assets
The most disturbing allegations concern personal information belonging to people who had died, which prosecutors say Choi accessed through her employment at a Los Angeles-area funeral home before she and Shin transmitted identifying details to Shachar for payment.
The transferred information allegedly included names, Social Security numbers, dates of birth, Medicare identification numbers, death dates and times, primary-care physician names, next-of-kin information, and photographs of identity documents sent through text and WhatsApp messages.
Prosecutors say Shachar, a nurse working for him, or Choi then contacted surviving relatives by telephone or met them at the funeral business to collect additional health information, while hospice employees allegedly sought records from the deceased person’s recent hospital visits.
The indictment alleges that Shachar directed a nurse, an unnamed physician, and others to build false, backdated electronic charts asserting that the deceased beneficiaries had received nursing evaluations before death and had been medically certified as terminally ill.
Shachar allegedly paid Choi and Shin between $1,000 and $3,000 for each deceased beneficiary enrolled through this process, a significantly higher referral price than the amounts described for living patients and an alleged reflection of the billing value attached to a completed death.
Prosecutors contend that the alleged operation accepted only certain deceased individuals, including people who died at home, died within five days of marketer contact, and were not already receiving hospice care, conditions allegedly chosen to make the retrospective paperwork less likely to collide with existing records.
The indictment also says the funeral business provided accurate death times so hospice records could be arranged around those immutable facts, while relatives could be approached to sign enrollment paperwork after the beneficiary was no longer alive to authorize or question the claimed care.
Investigators allege that deceased-patient billing served a second strategic purpose by lowering the hospices’ apparent live-discharge rate, which otherwise could reveal that unusually large numbers of supposedly terminal patients survived long enough to leave hospice and potentially trigger closer review.
The same alleged tactic could also offset Medicare’s annual per-patient spending limitation, prosecutors say, because short retrospective enrollments involving people who had actually died could make the patient population appear more clinically plausible while generating additional reimbursable days.
The identity component illustrates a broader vulnerability examined in Amicus International Consulting’s analysis of how stolen and deceased identities can penetrate official systems, although the Shachar indictment concerns alleged Medicare billing rather than travel documentation.
A separate Amicus examination of the legal consequences surrounding fabricated deaths and misused deceased-person records similarly underscores why death data, government identifiers, and official documentation require rapid reconciliation across agencies and private institutions.
Nearly $26.9 million allegedly flowed from Medicare
The indictment’s financial totals distinguish the amount submitted from the amount paid, alleging approximately $27,731,000 in false claims and approximately $26,908,000 in reimbursements, figures that place the alleged loss far beyond a handful of disputed certifications or isolated coding mistakes.
That difference of roughly $823,000 indicates that most billed amounts cleared the payment system, leaving investigators to examine not only whether individual patients qualified, but also how the companies’ documentation, ownership, referral relationships, and enrollment patterns escaped earlier intervention.
One money-transaction count alleges that Shachar caused $15,000 to be wired from a Holly Trinity Hospice bank account in September 2024 as part of a down payment on a lease-to-own Rolls-Royce Phantom, which prosecutors characterize as property derived from healthcare fraud.
The indictment’s forfeiture allegations seek proceeds traceable to any proven offenses and permit the government to pursue substitute property under specified conditions, but those provisions are requests tied to a future conviction rather than findings that any listed asset has already been criminally forfeited.
Local coverage by FOX 11 Los Angeles placed the case within the region’s wider enforcement sweep, highlighting the unusual use of deceased-patient information and the government’s increasingly aggressive focus on suspicious hospice billing across Southern California.
A 16-count indictment reaches beyond ordinary billing disputes
The grand jury charged all three defendants with conspiracy to commit healthcare fraud, substantive healthcare fraud, and aggravated identity theft, while Shachar alone faces additional allegations involving a transaction in criminally derived property and multiple violations of the federal Anti-Kickback Statute.
Counts two through nine identify representative Medicare claims tied to each of the four hospices, while counts ten through twelve allege unlawful use of three deceased beneficiaries’ names, Social Security numbers, and Medicare identifiers during specified healthcare fraud offenses.
Count thirteen addresses the alleged Rolls-Royce payment, counts fourteen and fifteen identify alleged referral payments, and count sixteen alleges that Shachar sold or distributed nine beneficiaries’ Medicare identifiers to an unnamed physician for $12,500 in March 2025.
Aggravated identity theft is especially consequential because a conviction ordinarily carries a mandatory prison term that must run consecutively to punishment for the underlying felony, increasing the stakes whenever prosecutors can connect an unlawfully used identifier to a qualifying fraud offense.
The Department of Justice has said convictions on all charged offenses could expose the defendants to decades in federal prison, although any actual sentence would depend on proven counts, statutory requirements, federal guidelines, judicial findings, and each defendant’s circumstances.
The alleged scheme reveals recognizable oversight signals
Although prosecutors have not publicly disclosed every analytical method used to build the case, the indictment describes patterns compliance teams commonly examine, including recurring marketer payments, extended enrollment of nonterminal patients, post-death documentation, unusually low live-discharge rates, and concentrated ownership across providers.
Death-date reconciliation offers one particularly powerful control because Medicare claims, hospice election records, hospital encounters, funeral-home data, and state vital statistics should form a coherent timeline, while retroactive entries created after death may reveal impossible visits or suspiciously compressed documentation.
Cross-provider ownership analysis is equally important because reviewing each hospice independently could obscure common bank transfers, employees, physicians, marketers, communication accounts, and beneficiary movements, whereas network analysis can expose shared control and coordinated billing behavior across nominally separate companies.
Beneficiary interviews also remain indispensable, since patients may reveal that they never understood they were electing hospice, were promised general wellness services, received money or furniture, continued seeking curative treatment, or never encountered the clinicians named in their medical records.
For families of deceased beneficiaries, explanation-of-benefits statements and Medicare account histories can provide early warnings when they list hospice dates, provider names, equipment, or professional visits that relatives know never occurred before their loved one died.
Yet the alleged use of grieving relatives demonstrates why consumer vigilance cannot substitute for institutional controls, because families arranging funerals are poorly positioned to recognize that requests for health information or signatures might later support claims presented as pre-death medical services.
Los Angeles case forms part of a national enforcement surge
The Shachar prosecution emerged through the 2026 National Health Care Fraud Takedown, a coordinated federal initiative that announced charges against 455 defendants across dozens of judicial districts involving alleged schemes collectively responsible for more than $6.5 billion in false claims.
Federal officials described the nationwide action as a collaboration among prosecutors, the Federal Bureau of Investigation, health-inspector teams, drug-enforcement personnel, state Medicaid fraud units, and other partners combining criminal investigations with administrative payment suspensions and provider exclusions.
Southern California received particular attention because its dense population of Medicare beneficiaries, healthcare businesses, marketers, laboratories, pharmacies, home-health agencies, and hospice providers creates legitimate service demand alongside opportunities for layered referral and billing arrangements that can be difficult to unwind.
The Shachar allegations are distinct from other cases announced during the takedown, and combining defendants or dollar totals would be misleading, yet their inclusion in one enforcement campaign shows how authorities increasingly treat healthcare fraud as interconnected financial, identity, and data crime.
This approach reflects a broader shift from reviewing single suspicious claims toward mapping networks of owners, recruiters, clinicians, beneficiaries, bank accounts, devices, and communication channels, allowing investigators to detect common control even when businesses use separate corporate registrations and billing numbers.
Patients and families face harms beyond financial loss
Improper hospice enrollment can create consequences that extend well beyond taxpayer loss, because a beneficiary classified as terminal may encounter confusion over curative treatment, disrupted relationships with established physicians, unfamiliar home visits, altered medication decisions, and records that inaccurately describe a life-limiting diagnosis.
Legitimate hospice providers also suffer when alleged fraud consumes public funds and damages trust, since families may become suspicious of appropriate end-of-life recommendations, clinicians face heavier documentation demands, and honest operators must compete against businesses allegedly subsidized by unlawful referrals.
For surviving relatives, learning that a loved one’s identity may have been converted into posthumous billing can reopen grief and generate practical burdens, including reviewing medical files, reporting identity misuse, disputing claims, and determining whether sensitive information was shared beyond the original scheme.
Taxpayers bear the direct financial cost, but the deeper institutional loss arises when payments intended for nursing, pain control, equipment, counseling, and family support are diverted from beneficiaries who genuinely qualify for compassionate care during their final months.
The case therefore sits at the intersection of healthcare integrity and identity security, demonstrating how reliable death reporting, controlled access to beneficiary data, physician accountability, corporate transparency, and fast payment analytics must operate together rather than as separate compliance functions.
What happens next in the Oren Shachar case
The Justice Department’s June 23 announcement said Shachar and Shin had been released on bond and were scheduled for trial on August 11, although federal trial dates can change through later court orders as discovery, motions, negotiations, and scheduling issues develop.
Prosecutors must prove far more than the existence of inaccurate claims, because criminal conviction requires evidence establishing the defendants’ knowledge and intent, their respective roles, the falsity or ineligibility of charged services, and the connection between alleged payments, identifiers, records, and Medicare reimbursements.
Defense lawyers may challenge witness credibility, the interpretation of hospice eligibility, ownership-and-control evidence, the authenticity or context of electronic communications, the calculation of alleged losses, and whether particular payments or services had legitimate explanations rather than criminal purposes.
Future proceedings may also determine whether challenged evidence is admissible, whether charges remain joined for trial, whether any defendant reaches a plea agreement, and whether the government can trace specific assets to the alleged fraud under federal forfeiture standards.
Until a jury returns verdicts or defendants enter accepted guilty pleas, descriptions of the enterprise must remain allegations, and neither the scale of the claimed loss nor the emotional force of deceased-patient accusations can replace the government’s burden of proof.
Nevertheless, the indictment offers a detailed warning for Medicare administrators, hospice owners, clinicians, funeral businesses, and families: personal data gathered during illness and death can become financially valuable when disconnected systems fail to reconcile identity, eligibility, clinical service, and payment.
The Oren Shachar Medicare fraud case will now test whether prosecutors can convert an elaborate paper trail into proof beyond a reasonable doubt, while its broader legacy may depend on whether agencies can prevent similar claims before money leaves Medicare rather than recovering funds after vulnerable identities have already been exploited.
